Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page build/version indicator from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site update rather than a change to the underlying trial record history.
    Difference
    0.0%
    Check dated 2026-04-25T18:44:12.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Added revision label v3.5.2 to the history and removed the v3.5.0 entry.
    Difference
    0.0%
    Check dated 2026-04-18T13:35:53.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the page history. Removed Revision: v3.4.3 from the history.
    Difference
    0.0%
    Check dated 2026-03-21T00:44:49.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2 from the Record History.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:24.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    New revision added: v3.4.2, replacing v3.4.1 in the history. No substantive page content changes are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:55.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    An additional revision entry v3.4.1 is added and the previous v3.4.0 entry is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:24:18.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.